4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-088039
Chief Executive Officer gave up 58,712 shares (to pay taxes)
- Chief Executive Officer acquired 540,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2015-12-30 | Shares withheld for taxes | −58,712 | $6.13 | $359,905 | 561,461 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2016-01-01 | Grant or award | +540,000 | 1,101,461 | D | ||
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2016-01-01 | Grant or award · Stock Options | +80,000 | 1,166,466 | D | ||
Loading xslF345X03/doc4.xml…